Nonpharmacological interventions to treat physical frailty and sarcopenia in older patients : a systematic overview - the SENATOR Project ONTOP Series by Lozano-Montoya, Isabel et al.
© 2017 Lozano-Montoya et al. This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php 
and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you 
hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission 
for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
Clinical Interventions in Aging 2017:12 721–740
Clinical Interventions in Aging Dovepress
submit your manuscript | www.dovepress.com
Dovepress 
721
R e v I e w
open access to scientific and medical research
Open Access Full Text Article
http://dx.doi.org/10.2147/CIA.S132496
Nonpharmacological interventions to treat 
physical frailty and sarcopenia in older patients: 









1Servicio de Geriatría, Hospital 
Universitario Ramón y Cajal 
(IRYCIS), Madrid, Spain; 2Geriatrics 
and Geriatric emergency Care, 
Italian National Research Center 
on Aging (IRCCS-INRCA), Ancona, 
Italy; 3Department of Medicine 
for the elderly, National Health 
Service Grampian, Aberdeen, UK; 
4Department of Medicine, University 
College Cork, Cork, Ireland
*These authors contributed equally 
to this work
Background: Physical frailty (PF) and sarcopenia are predictors of negative health outcomes 
such as falls, disability, hospitalization, and death. Some systematic reviews (SRs) have been 
published on different nonpharmacological treatments of frailty and sarcopenia using hetero-
geneous definitions of them.
Objective: To critically appraise the evidence from SRs of the primary studies on nonphar-
macological interventions to treat PF (defined by Fried’s frailty phenotype) and sarcopenia 
(defined by the EWGSOP) in older patients.
Design: Overview of SRs and meta-analysis of comparative studies.
Data sources: PubMed, Cochrane Database of Systematic Reviews, EMBASE, and CINAHL 
were searched in October 2015.
Eligibility criteria for selecting studies: SRs that included at least one comparative study 
evaluating any nonpharmacological intervention to treat PF or sarcopenia in older patients in 
any health care setting. Any primary study described in these SRs with experimental design 
was included.
Data extraction and management: Two reviewers independently screened titles, abstracts, 
and full-texts of articles. Quality assessment was carried out by using criteria from the Cochrane 
Collaboration and the GRADE working group.
Results: Ten SRs with 5 primary studies satisfied the inclusion criteria. The most frequent 
interventions in the included studies were physical exercise (4) and nutritional supplementation (2). 
Muscle strength (MS; except for one study in a frail population) and physical performance 
(PP; except for another study in a frail population) improved with exercise and amino acid 
supplementation in frail and sarcopenic old adults. Falls and activities of daily living were 
assessed in two studies with opposite results. The overall quality of the evidence was low.
Conclusion: This overview of SRs highlights the importance of exercise interventions with 
or without nutritional supplementation to improve the PP in community-dwelling patients 
aged .65 years with PF and sarcopenia. MS improved with multidisciplinary treatment and 
exercise interventions in this population.
Keywords: review, exercise, nutrition, older adults
Introduction
Frailty can be seen as the weakening of health (defined as the resilience or capacity to 
cope and to maintain and restore one’s integrity, equilibrium, and sense of well-being 
in three domains: physical, mental, and social).1,2 Clinically, it has been defined as 
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a “multidimensional syndrome characterized by decreased 
reserve and diminished resistance to stressors.”2 It is consid-
ered a treatable condition that may be reversible.3 Although 
no definition is universally accepted, two predominant 
models have emerged to understand frailty:1,4 Fried’s phe-
notypical approach to physical frailty (PF)5 and Rockwood’s 
operationalization of a model of accumulation of deficits.6 
In the current scientific literature, Fried’s phenotype is the 
most widely used method to define,7 where PF is defined 
as a multifactorial syndrome characterized by diminished 
strength, endurance, and reduced physiologic function that 
increases an individual’s vulnerability to develop increased 
dependency and/or death.2 Rockwood’s Index considers not 
only the physical aspects of frailty but also other domains 
such as psychological and social domains. A major difference 
is that the latter model may include any degree of disability as 
a vulnerability factor (ie, present disability increases frailty), 
whereas the former model considers frailty as a vulnerability 
to disability, as the previous stage to disability. These two 
approaches should be considered as complementary and not 
mutually exclusive.8
Sarcopenia is the presence of low muscle mass plus low 
muscle function (muscle strength [MS] or physical perfor-
mance [PP]) associated with aging.9 Recent research has 
highlighted sarcopenia as the biological substrate of PF,10 
skeletal muscle decline being one of its key components. 
Recent research confirms that Fried’s frailty phenotype and 
the European Working Group on Sarcopenia in Older People 
(EWGSOP)-defined sarcopenia are strongly correlated.11 Both 
the entities are the predictors of negative health outcomes such 
as falls, disability, hospitalization, and death.12–17 Interventions 
are necessary to reverse the frailty status and to treat sarcope-
nia in order to avoid further negative health outcomes.3
Some systematic reviews (SRs) have been published in 
recent years on different nonpharmacological treatments 
of frailty and sarcopenia (physical exercise and nutritional 
supplementation being the usual components). However, the 
current definitions of frailty and sarcopenia that are in use 
are heterogeneous, and different inclusion criteria have been 
used. Therefore, the aims of this overview of reviews were as 
follows: 1) to identify all published SRs on nonpharmacologi-
cal interventions of PF (defined by Fried’s frailty phenotype) 
and sarcopenia (defined by the EWGSOP), 2) to identify and 
critically appraise the primary studies included in these SRs 
by using the Optimal evidence-based Non-drug Therapies in 
Older People (ONTOP) methodology,18 and 3) to critically 
summarize the evidence and emphasize its limitations in 
order to suggest research priorities for future studies.
Methods
This paper is part of the ONTOP project, a work package of 
a European Union-funded FP 7 research named SENATOR 
(Software ENgine for the Assessment & Optimization of 
drug and non-drug Therapy in Older persons [www.senator-
project.eu]); detailed methodology of ONTOP has been 
published previously.18 Briefly, the ONTOP objective is to 
develop a literature overview of reviews of nonpharmacologi-
cal treatments of 10 prevalent medical conditions affecting 
older people. The present paper reports evidence-based 
interventions for the treatment of sarcopenia and frailty in 
older people.
The ONTOP Evidence Group defined the clinical ques-
tions according to the Grading of Recommendations Assess-
ment, Development and Evaluation (GRADE)19 method. 
A Delphi process using a group of independent international 
experts in Geriatric Medicine helped to establish the criti-
cal outcomes that should be considered for selecting papers 
and reporting results in this review (Table 1). Most critical 
outcomes included measures of muscle function, and some 
of them were compound variables. The expert group did not 
consider muscle mass as a critical outcome. Table 1 also lists 
the methods that were acceptable to assess each variable, 
following the EWGSOP recommendations.
Table 1 Delphi-defined critical outcomes for studies on interven-
tions on physical frailty and sarcopenia and assessment methods 
for each outcome
Critical outcomes Assessment methods
Muscle strength Handgrip strength
Knee flexion/extension
Peak expiratory flow
Physical performance Short Physical Performance Battery
Usual gait speed
Timed Up and Go Test






+ physical performance assessment
Muscle mass and 
muscle function
Bioimpedance analysis
Dual energy X-ray absorptiometry
Computer tomography
Magnetic resonance imaging
Total or partial body potassium per 
fat-free soft tissue
Anthropometric measures
+ muscle function assessment
Activities of daily living Barthel index
Lawton index
Falls Falls
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Nonpharmacological interventions to treat physical frailty and sarcopenia
Search strategy and selection of SRs
Search strategies were launched in October 2015 in the 
following databases: Cochrane Database of Systematic 
Reviews, PubMed, EMBASE and CINAHL (Supplementary 
material 1). Montori’s highly specific strategy was used for 
PubMed database.20
Two criteria were considered for further evaluation of any 
published abstract: 1) a paper defined as SR or meta-analysis 
and 2) the use of any nonpharmacological intervention for 
PF (defined by Fried’s phenotype, either original or adapted)5 
or sarcopenia (defined by the EWGSOP).9 Other records 
such as guidelines, conference proceedings, and program 
abstracts were excluded.
Later, full-texts of all relevant abstracts were obtained 
and screened to identify SRs of interest based on 1) the use 
of at least one medical literature database; 2) the inclusion 
of at least one primary study; 3) the use of at least one 
nonpharmacological intervention to treat PF or sarcopenia; 
and 4) the mean age of the subjects was .65 years. SRs 
written in English, Italian, Portuguese, or Spanish were 
considered.
Inclusion and exclusion criteria for 
primary studies
The included SRs were examined to identify any experimental 
comparative study, either randomized or nonrandomized, 
that investigated any nonpharmacological intervention to 
treat PF or sarcopenia in older patients.
Primary studies were excluded if they were observational 
studies or before–after studies with historical controls. 
Studies were also excluded when the mean age of subjects 
was ,65 years, when frailty was assessed by using methods 
other than Fried’s criteria, and when sarcopenia was not 
defined by the EWGSOP criteria. Trials with mixed frail and 
prefrail subjects were also excluded. Studies using conditions 
to define the population (eg, diabetes, COPD, and cancer) or 
using special populations (eg, athletes) were also excluded, 
as well as those exclusively considering patients admitted to 
intensive care or palliative care units. Only nutritional inter-
ventions that considered macronutrients were included; those 
using individual vitamins or micronutrients were excluded, as 
they were considered pharmacological interventions. Trials 
that did not assess any critical outcome (Table 1) were also 
excluded.
Data extraction and management
Results from primary studies were transferred onto data 
extraction forms. Information collected included trial 
and patient characteristics, intervention and comparator 
components as well as outcome measures. Two reviewers 
independently screened titles, abstracts, and full-texts of 
articles. Disagreement was resolved by discussion and, when 
needed, by a third senior reviewer.
Risk of bias assessment
Assessment of bias in the included primary studies was 
carried out by using criteria from the Cochrane Collabora-
tion.21 Domains assessed were random sequence generation, 
allocation concealment, blinding of participants and person-
nel, blinding of outcome assessment, incomplete outcome 
data, selective reporting, and other potential biases such as 
differences in baseline conditions. Overall risk of bias was 
graded by including each study in one of three categories: 
low risk, high risk, and unclear risk. Two reviewers inde-
pendently assessed the risk of bias of individual studies, and 
any differences in quality assessment results were resolved 
through consensus.
Issues on the unit of analysis
Subjects were treated as the unit of analysis in all primary 
studies included in this review.
Data synthesis and analysis
The results were presented in a narrative way with the infor-
mation provided by the included studies. Nonpharmacologi-
cal interventions varied widely across studies, and therefore, 
meta-analysis was not feasible.
Grading the quality of evidence
The quality of evidence was assessed with GRADE 
(Grading of Recommendations, Assessment, Development 
and Evaluation) methodology.19 GRADE assessment consid-
ers the risk of bias, consistency of results across the available 
studies, precision of the results, directness, and likelihood of 
publication bias, dose–response, and strength of the associa-
tion, as well as plausible confounders that may have influence 
on the effect of the intervention. The quality of the evidence 
was categorized as high, moderate, low, or very low based 
on the authors’ judgments for the critical outcomes.
Results
SRs
This search identified 9,277 abstracts after removing dupli-
cates (Figure 1). Among the 130 reviews identified for full-
text evaluation, 10 were included (Table 2) and 120 were 
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were not defined using Fried’s or EWGSOP criteria. 
The publication year of the SR included ranged from 1979 
to 2015. These reviews were heterogeneous, encompass-
ing nonpharmacological interventions such as nutritional 
supplementation and physical exercise for the treatment of 
PF and sarcopenia (Table 3).
Primary studies
Overall, the 10 SRs22–31 yielded 140 primary studies, of 
which 732–38 satisfied the inclusion criteria, but three of 
these presented the results of the same study. An additional 
relevant study was included after manual search39 (Table 4). 
The six primary studies finally included are listed in Table 5. 
Table 6 summarizes the risks of bias in each study, which 
was mostly low due to the nature of the interventions except 
for performance bias.
Sarcopenia
Five out of 10 SRs22–26 included sarcopenic populations. From 
these SRs, only one primary study (Kim et al)32 satisfied the 
inclusion criteria. In most cases, subjects were not defined by 
having sarcopenia, but by a range of other conditions, and in 
many cases, healthy subjects were included (Supplementary 
material 2). In addition, one relevant study was found after 
manual search.39
evidence of exercise and amino acid supplementation 
(AAS) to treat sarcopenia in community-dwelling 
older people
One randomized controlled trial (RCT)32 evaluated four inter-
ventions: a multicomponent exercise program (MCEP), AAS, 
MCEP with AAS, and health education (HE) in 155 Japanese 
sarcopenic community-dwelling women. PP and MS were 
the outcome measures. After the 3-month intervention, MS 
assessed by knee extension improved only with the combi-
nation of MCEP and AAS (strength increased by 7%) com-
pared with HE (12.3% strength loss, P=0.02). PP assessed 
by 5-m usual gait speed improved in MCEP (+0.19 m/s) 
and MCEP + AAS groups (+0.16 m/s) compared with HE 
(+0.03 m/s, P=0.0017). The authors of this trial concluded 
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Nonpharmacological interventions to treat physical frailty and sarcopenia
that exercise and nutrition may be necessary to reverse the 
effects of sarcopenia in community-dwelling older women, 
but research on larger populations and also in males is needed 
to confirm these results.
A second RCT39 evaluated the effects of exercise (resis-
tance training; RT) in combination with AAS (collagen 
peptides) versus exercise with placebo during 3 months in 
53 older community-dwelling sarcopenic men. Knee exten-
sion strength was used as the outcome measure. MS improved 
significantly in both the groups after 12 weeks, the effect 
being higher in the collagen peptide group (+13.82%) than in 
the placebo group (+5.3%, P,0.05). Authors suggested that 
these results might be due to the intensive training designed 
to induce muscular hypertrophy and the collagen effects on 
increasing muscle mass.
We did not poll these studies due to differences between 
participants and interventions used. In both the studies, 
blinding of participants was not possible due to the nature 
of the intervention. Methodological issues are synthesized 













To recommend training supervised 
exercise programs to improve muscle 
strength, gait ability and fall risk
.70 1990–2012 RT, eT, BT, BwRT, MCeP, TAI, 
FT, COOT, SUP




To review the effect of nutrition and 
exercise interventions on muscle 
function
.50 2000–2013 RT, PA, multipurpose e, Prot, 
eAA, HMB, fatty acids, eS
MS, PP 1 out 
of 19
Finger et al24 To summarize whether protein 
supplementation could optimize 
the effects of resistance training on 
muscle strength
.60 Up to 
January 2014
RT + Prot (or modified diet with 
increased protein content) vs RT 
vs RT + with non-Prot placebo 
supplementation
MS 1 out 
of 9
Komar et al25 To synthesize the literature relating 
to leucine supplementation on muscle 
strength
.65 Up to 
February 2014
Supplementation with Leu (at least 
2 g/day)




To analyze the effects of 
supplementation on muscle function
.65 1991–2012 Nutritional supplementation (AAS/
ALA/EAA/HMB/Leu/Prot) ± e  
($8 weeks)





To examine the effectiveness 
of combined diet and exercise 
interventions to improve physical 
function
$65 April 2013 Diet interventions (based 
on dietary modification) ± e 
(RT/ST/STR/FT/BT)














Orr29 To review the effect of whole body 
vibration exposure on functional 
mobility
$45 Up to 
October 2014




To compare any physical exercise 
intervention to a control group on 
dual-task interference during walking
$60 Up to 
September 2014




To summarize how exercise affects 
dual-task performance
.59 Up to 
October 2013
Dual-task interventions, e, BT, TAI PP 1 out 
of 17
Abbreviations: AAS, amino acid supplement; ADL, activities daily living; ALA, alpha-linoleic acid supplement; BT, balance training; BwRT, body weight resistance training; 
COOT, coordination training; E, exercise; EAA, essential amino acid supplementation; ES, electrical stimulation; ET, endurance training; F, falls; FT, flexibility training; HMB, 
beta-hydroxy-beta-methylbutyrate supplement; Leu, leucin supplement; MCeP, multicomponent exercise program; MS, muscle strength; PA, physical activity; PP, physical 
performance; Prot, protein supplement; PRT, progressive resistance training; RT, resistance training; SR, systematic review; ST, strength training; STR, stretching; SUP, 
supplementation; TAI, Tai-Chi exercise; wBv, whole body vibration; wBve, whole body vibration plus exercise.
Table 3 Nonpharmacologic interventions to treat physical frailty 
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in Table 6. According to GRADE assessment, the quality 
or certainty of the evidence has been assessed as very low 
(Table 7) for the critical outcomes.
PF
Five out of 10 SRs27–31 included physically frail populations. 
From these SRs, 4 RCTs33–38 (described in 6 articles) were 
included; three articles33–35 described different aspects of 
the same study (the Frailty Intervention Trial – FIT), so that 
they are reported together here. Again, the main reason of 
exclusion was the use of varied nonstandard definitions of 
frailty (Supplementary material 3).
The number of patients included in these trials ranged from 
32 to 241. All trials included participants over 70 years old, 
except one study performed in nursing homes, that included 
patients aged over 85 years.36 One trial included only women.38 
The study characteristics are described in Table 5. In general, risk 
of bias was low, except for blinding of participants (Table 6).
Efficacy
This study considered that data of these studies could not be 
combined due to differences between the nonpharmacologi-
cal interventions used.
evidence on multidisciplinary interventions in 
physically frail community-dwelling older people
A single study, The Frail Intervention Trial (FIT)40–42 evaluated 
the effects of an individualized multidisciplinary intervention 
versus usual care in 241 physically frail community-dwelling 
older people. The assessed outcomes of interest were MS, PP, 
falls and activities of daily living (ADL). After 12 months, 
there was a reduction in MS, assessed by knee extension 
strength, in both the groups: -16.41% in the intervention 
group versus -25.8% in the control group. This reduction 
was lower in the intervention group than the control group 
(between-group difference 1.84 kg, 95% confidence interval 
[CI] 0.17–3.51, P=0.03). PP, assessed by Short Physical Per-
formance Battery (SPPB), just increased in the intervention 
group: +0.68 points versus -1.05 points in the control group 
(between-group difference at 12 months is 1.58 points, 95% 
CI 1.02–2.14, P#0.001). There was an increment in 4-m walk 
test of +0.07 m/s in the intervention group compared with no 
changes in the control group (between-group difference at 
12 months 0.06 m/s, 95% CI 0.01–0.10, P=0.02). MS, assessed 
by handgrip, was higher in the control group: +0.93 kg in the 
intervention group versus +1.88 kg control group although no 
significant differences were found between groups (1.18 kg, 
95% CI -013 to 2.49, P=0.08). In addition, no significant 
differences were found in ADL, assessed by Barthel Index 
(BI) between groups after 12-month intervention (0.67 points, 
95% CI -4.23 to 5.56, P=0.79). BI was higher in the control 
group than the intervention group (6.14 vs 5.56). There was 
no effect of the intervention on the rate of falls that was also 
similar in the intervention group (183 falls, 1.54 falls per 
person, standard deviation [SD] 2.58) and the control group 
(178 falls, 1.50 falls per person, SD 2.39) with an incidence 
rate ratio of 1.12 (95% CI 0.78–1.63, P=0.53).
The risk of bias according to methodological issues was 
low except for performance and detection bias (Table 6). The 
quality or certainty of the evidence has been assessed as low 
(Table 8A) for the critical outcomes.
evidence on vibration exercise in physically frail 
community-dwelling older people
A pilot RCT37 assessed the efficacy of whole-body vibration 
exercise (WBVE) versus usual care that included different 




Sarcopenia (EWGSOP) Physical frailty (Fried’s criteria)





et al38Fairhall et al33 Cameron et al34 Fairhall et al35
Cadore et al22 X
Malafarina et al26 X
Cruz-Jentoft et al23 X
Komar et al25 X
Finger et al24 X
Manual search X
Gine-Garriga et al27 X X
Zanotto et al31 X
de Labra et al28 X X X
Orr29 X
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Nonpharmacological interventions to treat physical frailty and sarcopenia
physical therapies and routine exercises, in 44 frail older 
Chinese subjects (mean age ± SD =85.3±3.6 years) during 
8 weeks. Both the groups showed an improvement in MS 
(bilateral knee extension strength) by 52.31% versus 35.18% 
on the right leg and 61.78% versus 25.62% on the left leg 
in the intervention group versus control group, respec-
tively. Moreover, PP (Timed Up and Go Test [TUGT]) also 
improved in both the groups: -19.13 s in the intervention 
group versus -7.37 s in the control group. These differences 
were statistically significant between groups (P,0.05). 
However, further studies with larger sample sizes, longer 
study period, and follow-up period are needed to confirm 
these results.
The risk of bias according to methodological issues was 
low except for performance, attrition, and reporting bias 
(Table 6). In general, the quality or certainty of the evidence 
has been assessed as very low (Table 8B) for the critical 
outcomes.
evidence on exercise plus nutritional 
supplementation in physically frail community-
dwelling older people
One RCT38 evaluated the combined and separate effects of 
a MCEP and supplementation with milk fat globule mem-
brane (MFGM) in 131 Japanese women aged .75 years 
during 3 months of intervention and 4 months of additional 
follow-up. The outcomes assessed were MS (handgrip 
strength and knee extension strength) and PP (5-m usual gait 
speed and TUGT). After 3-month intervention, there were 
no significant differences between groups in MS improve-
ment. PP assessed by 5-m usual gait speed improved in the 
MCEP + MFGM group (0.1 s) compared with the MFGM 
group (0.02 s, P=0.005). TUGT also improved with the 
MCEP + MFGM group (1.65 s) and the MCEP + placebo 
group (2.02 s) compared to MFGM (0.24 s) and placebo 
group (0.44 s, P,0.001). However, an analysis of the effects 
of the intervention revealed that these effects were not main-
tained at 4 months of follow-up.
The risk of bias according to methodological issues was 
low except for selection, performance and reporting bias 
(Table 6). In general, the quality or certainty of the evidence 
has been assessed as very low (Table 8C–F) for the critical 
outcomes.
evidence on exercise in physically frail older people 
living in nursing homes
Finally, a single RCT36 evaluated the efficacy of a MCEP 
(resistance, balance, and gait training) versus passive stretches 
in 24 nonagenarian institutionalized Spanish subjects during 
12 weeks. The outcomes evaluated were MS (handgrip 
strength, knee extension strength), PP (5-m usual gait speed 
and TUGT), incidence of falls, and ADL status (BI). After 
the training period, there were significant differences between 
groups in MS (P,0.01): handgrip strength and knee exten-
sion strength improved by 11% and 20%, respectively, in 
the intervention group versus a reduction of 17% and 14%, 
respectively, in the control group. Moreover, the exercise 
group had a lower incidence of falls (from 0.77 to 0) and 
less ADL (BI score) deterioration than the control group with 
significant difference between them (P,0.001). There were 
no significant differences in PP between groups.
The risk of bias according to methodological issues was 
low except for performance, attrition, and reporting bias 
(Table 6). In general, the quality or certainty of the evidence 
has been assessed as very low (Table 8G) for the critical 
outcomes.
Summary of main results
This overview was aimed to identify SRs of nonpharmaco-
logical interventions used to treat PF and sarcopenia in older 
patients from different care settings. From 10 SRs22–31 meet-
ing the inclusion criteria, data from 5 RCTs (7 articles)3–38 
and one additional identified RCT,39 all published in the 
last 4 years were examined. In order to provide a summary 
for decision makers and guideline developers, the risk 
of bias (RoB) and the GRADE quality of evidence were 
assessed across outcomes for each individual study. The 
overall GRADE quality of evidence was judged to be low 
(Tables 7 and 8). In summary, this evidence points to some 
efficacy of physical exercise programs (that include resis-
tance and balance training) in improving relevant outcomes. 
An additional relevant finding is the small number of articles 
that use standard definitions of frailty and sarcopenia.
Discussion
Agreements and disagreements with 
other studies or reviews
Some guidelines issued by official organizations have 
included recommendations on frailty. The Agency for 
Healthcare Research and Quality guideline43 recommends 
physical activity and monitoring diet and body weight as the 
main strategies to stabilize and control frailty. The British 
Geriatrics Society (BGS)44 recommends a holistic medical 
review based on the comprehensive geriatric assessment as 
gold standard to create an individualized care and support 































































Powered by TCPDF (www.tcpdf.org)
                               1 / 1





seem to support this recommendation, as it showed significant 
improvement on MS and PP (SPPB, gait speed) with a multi-
disciplinary intervention based on the assessment of deficien-
cies versus usual care. In addition, the BGS44 recognizes that 
exercise, in particular strength and balance training, improves 
both mobility and functional ability. However, the optimal 
exercise regimen to minimize frailty and sarcopenia remains 
uncertain. Moreover, the BGS indicates that nutritional 
interventions also need to be considered, although evidence 
to support this remains limited. Nutrition recommendations 
currently include optimizing protein intake and correcting 
vitamin D insufficiency. The European Society for Clini-
cal Nutrition and Metabolism (ESPEN)40 recommends that 
the diet should provide at least 1.0–1.2 g protein/kg body 
weight/day and up to 1.2–1.5 g protein/kg body weight/day 
for malnourished/at risk of malnutrition older people, but this 
recommendation is based on data coming from longitudinal 
epidemiological studies, not on intervention trials. Higher 
intake of proteins is recommended for individuals with severe 
illness or injury. Daily physical activity or exercise (RT and 
aerobic exercise) should be undertaken by all older people, 
for as long as possible. These recommendations are in line 
with the results of the study by Kim et al in 201232 included 
in this overview: an improvement in MS and PP (measured 
by GS) was achieved with the combination of exercise and 
AAS. However, in the study by Kim et al in 2015,38 based on 
nutritional supplementation with phospholipids, an improve-
ment only on PP was shown.
Although MS and PP are relevant intermediate outcomes,41 
the studies included in this overview did not show improve-
ments on hard outcomes, such as reduction in the incidence of 
falls or improved basic ADLs, with the exception of the only 
study performed in a very old population living in a nursing 
home.36 In this study, exercise significantly reduced the inci-
dence of falls and attenuated ADL functional loss. Current 
guidelines of frailty do not consider these outcomes.
The majority of the populations included in the studies 
selected in this overview are Asian (from China and Japan), 
except for the FIT33–35 study (Australian) and the study in nurs-
ing homes36 (Spanish). This is important because the results 
and conclusion from these trials may not be fully extrapolated 
to other populations and in other health care settings.
Strengths and weaknesses of the study
This study has several strengths compared with previously 
published studies, namely: 1) The authors conducted com-
prehensive searches in four electronic databases to ensure 
all published trials were identified. The search terms for 
this overview of SRs were intentionally broad to capture 
all studies, and this led to .9,000 abstracts. They used a 
multidisciplinary review group of authors with experience in 
conducting SRs to independently examine and select studies. 
2) This is the first overview of SRs fully designed to gather 
the evidence of nonpharmacological interventions on spe-
cific populations defined by validated definitions of PF and 
sarcopenia; hence, the populations considered in this review 
are relatively homogeneous. An issue raised in previous SRs 
was the heterogeneous populations defined by very different 
and nonstandardized criteria, both for sarcopenia and frailty. 
3) The interventions considered are deliverable in clinical 
practice. 4) The outcome measures considered in this study 
were pre-specified by a panel of experts and use validated 
and reproducible measures. Variability in outcome measures 
is limiting research in this area.42 5) The strength of evidence 
is evaluated according to the GRADE system.
On the other hand, this review has several limitations. 
First, the potential nondetection/nondiscovery of primary 
studies that were not found in any of the SRs. However, 
the methodology that is used has been previously used to 
gather evidence on other nonpharmacological approaches 
to common geriatric syndromes45–52 and is well described 
in medical research.18 Second, the arbitrary cut-off age of 
65 years may limit the applicability of the evidence from the 
present overview of SRs in patients aged ,65 years. More-
over, institutionalized patients are not well represented, and 
there are no data on hospitalized patients. Third, the studies 
included were heterogeneous in terms of interventions, with 
short intervention periods of 3 months in the majority of trials 
and scanty data on longer follow-up outcomes. The number 
of studies included and sample sizes were small, and as a 
result, meta-analysis was not possible.
Conclusion
General conclusion
This overview of SR highlights the importance of exercise 
interventions with or without nutritional supplementation to 
improve PP (TUGT, GS) in community-dwelling patients 
aged .65 years with PF and sarcopenia. MS was improved 
with multidisciplinary and exercise interventions in this 
population. However, more trials with precise definitions of 
sarcopenia and PF with standardized outcome measures are 
clearly needed, especially in nutrition intervention studies.
Implications for practice
Sarcopenia and frailty are associated with multiple adverse 
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Nonpharmacological interventions to treat physical frailty and sarcopenia
This overview suggests that resistance and balance exercise 
may be the first treatment step, with a possible effect of nutri-
tional supplementation added to exercise to improve outcomes. 
Exercise and nutritional interventions seem to be safe and 
are recommended from a public health point of view in older 
populations, both healthy or with a wide range of co-morbid 
problems. Therefore, there seem to be no clear reasons to avoid 
these interventions in frail or sarcopenic patients. However, 
expected impact on outcomes needs to be interpreted with cau-
tion due to methodological limitations in the small number of 
trials available and the risk of bias in several domains.
Implications of the research
This overview of SRs emphasizes the need for well-designed, 
large-scale RCTs with validated definitions of PF and sar-
copenia, and standardized outcomes before conclusions can 
be drawn on its effectiveness.
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